Renal epidermal growth factor precursor: proteolytic processing in an in vitro cell-free system

Area of Science:

• Biochemistry
• Renal Physiology
• Molecular Biology

Background:

• Membrane-bound renal epidermal growth factor precursor (proEGF) processing is crucial for kidney repair post-injury.
• The specific enzymes involved in proEGF processing and their role in nephrogenesis require elucidation.

Purpose of the Study:

• To investigate the enzyme machinery responsible for processing membrane-bound proEGF in renal tissues.
• To characterize the products of proEGF enzymatic degradation and their biological activity.
• To identify the class of enzymes involved in proEGF processing.

Main Methods:

• A cell-free system using isolated renal membranes incubated in vitro.
• High-Performance Liquid Chromatography (HPLC) and Western blotting for product analysis.
• Mitogenic activity assays using NRK-52E renal cells.
• Enzyme inhibition studies using heavy metal ions and protease inhibitors.

Main Results:

• Incubation of renal membranes released soluble EGF-immunoreactive products, including mature 6 kDa EGF and 45 kDa intermediate forms.
• Both mature EGF and 45 kDa forms exhibited mitogenic activity on renal cells.
• Enzymatic processing was inhibited by heavy metal ions (Cu2+, Zn2+) and protease inhibitors, implicating kallikrein-like serine proteases.

Conclusions:

• Renal membranes contain enzymes, likely kallikrein-like serine proteases, that process proEGF into biologically active soluble EGF.
• These findings suggest that renal kallikreins play a significant role in renal tubular regeneration by facilitating EGF release.
• The 45 kDa products are likely intermediates in the conversion of proEGF to mature EGF.